Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00729846 · ClinicalTrials.gov registry record · Phase 2
Bevacizumab in Combination With Visudyne Photodynamic Therapy (PDT)
A Phase 2 study, sponsored by California Retina Consultants.
- Completed
- Registry status
- Phase 2
- Development phase
- 22
- Enrollment target
NCT00729846 is a Phase 2 study that has completed, run by California Retina Consultants. The registered enrollment target is 22 participants.
The verdict
NCT00729846, a Phase 2 study, has completed, sponsored by California Retina Consultants.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 22 participants
- Enrollment target
Study Summary
To evaluate safety, visual acuity outcomes, persistence of choroidal neovascular leakage, and the number of treatments of combination intravitreal bevacizumab and verteporfin photodynamic therapy at standard or reduced fluence level in patients with subfoveal CNV due to age-related macular degeneration.
Interventions
- DRUG Bevacizumab
- DEVICE verteporfin photodynamic therapy reduced fluence
- DEVICE verteporfin photodynamic therapy standardfluence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2006-05 |
| Est. Completion | 2009-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00729846
The ClinicalTrials.gov registry entry for NCT00729846 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is California Retina Consultants, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Bevacizumab is the first listed.
NCT00729846 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00729846 about?
NCT00729846 is a clinical study titled "Bevacizumab in Combination With Visudyne Photodynamic Therapy (PDT)". To evaluate safety, visual acuity outcomes, persistence of choroidal neovascular leakage, and the number of treatments of combination intravitreal bevacizumab and verteporfin photodynamic therapy at standard or reduced fluence level in patients with subfoveal CNV due to age-related macular degenerat...
What is the current status of trial NCT00729846?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 22 participants. The study started on 2006-05. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00729846?
The interventions under investigation include: Bevacizumab (DRUG), verteporfin photodynamic therapy reduced fluence (DEVICE), verteporfin photodynamic therapy standardfluence (DEVICE).
Who is sponsoring clinical trial NCT00729846?
This trial is sponsored by California Retina Consultants, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.